| Literature DB >> 26552393 |
Tobias Revold1, Takele Abayneh2,3, Hege Brun-Hansen4, Signe L Kleppe5,6, Ernst-Otto Ropstad7, Robert A Hellings8, Henning Sørum9.
Abstract
Listeria monocytogenes has been reported to cause various infectious diseases in both humans and animals. More rarely, ocular infections have been reported. To our knowledge, only two cases of Listeria keratitis have been described in horses. We report kerato-conjunctivitis in four Norwegian horses associated with L. monocytogenes. Clinically, all cases were presented with recurrent unilateral kerato-conjunctivitis. L. monocytogenes bacteria were isolated from swab samples from all cases, and cytology carried out in 3 cases was indicative of L. monocytogenes infection. The present report describes the first known cases in which L. monocytogenes has been isolated from keratitic lesions in horses in Norway. A potential risk factor may be feeding of silage or haylage, but other sources of infection cannot be ruled out. The phenotypic features including antimicrobial susceptibility and serotype of the isolates are described. Laboratory detection of L. monocytogenes demands extra caution since only low numbers of bacteria were detected in the eye-swabs, probably due to the low volume of sample material and the intracellular niche of the bacterium. A general poor response to treatment in all these cases indicates that clinicians should pay extra attention to intensity and duration of treatment if L. monocytogenes is identified in connection with equine kerato-conjunctivitis.Entities:
Mesh:
Year: 2015 PMID: 26552393 PMCID: PMC4638104 DOI: 10.1186/s13028-015-0167-2
Source DB: PubMed Journal: Acta Vet Scand ISSN: 0044-605X Impact factor: 1.695
Fig. 1a. Squamous epithelial cell with typical rod-shaped bacteria on the surface. Note the absence of inflammatory cells. ×600 Modified Wright stain. b The rod-shaped bacteria are suggestive of L. monocytogenes. ×1000 Modified Wright stain
Key clinical observations, culturing results, topical and systemic treatments in four cases of equine keratitis
| Case No | Day after initial examination | Clinical diagnoses | Bacterial growth after culturinga | Topical medication (frequency)b | Systemic medication (days) |
|---|---|---|---|---|---|
| 1 | 1 | Conjunctivitis, moderate central superficial keratitis1 |
|
| – |
| 15 | Unchanged1 |
|
|
| |
| 55 | No symptoms2 | – | – | ||
| 69 | Conjunctivitis, moderate central superficial keratitis1 | Normal flora dominated by |
| – | |
| 114 | Unchanged1 |
|
|
| |
| 128 | Central superficial keratitis improved1 | No listerial growth (selective enrichment) |
| – | |
| 140 | Conjunctivitis, moderate central superficial keratitis1 |
| – | ||
| 150 ( | central superficial keratitis improved1 |
| – | ||
| 178 ( | Unchanged2 | ||||
| 2 | 1 | Conjunctivitis, mild–moderate central superficial keratitis1 |
|
| – |
| 12 | Mild keratitis1 |
| – | ||
| 29 | Conjunctivitis, mild–moderate central superficial keratitis, mild anterior uveitis1 |
|
| – | |
| 45 | No symptoms2 | – | – | ||
| 76 | Conjunctivitis, mild–moderate central superficial keratitis1 |
| – | ||
| 2200 | No further symptoms2 | – | |||
| 3 | 1 | Conjunctivitis, mild central superficial keratitis1 |
|
| – |
| 30 | Conjunctivitis2 |
| – | ||
| 44 | None2 | – | – | ||
| 48 | Conjunctivitis, mild central superficial keratitis1 |
|
| – | |
| 90 | None2 | ||||
| 104 | Conjunctivitis, mild–moderate central superficial keratitis1 |
|
|
| |
| 118 | Mild keratitis1 |
| – | ||
| 162 | No symptoms2 | ||||
| 4 | 1 | Mild central superficial keratitis1 |
| – | |
| 16 | Conjunctivitis2 |
| – | ||
| 28 | Conjunctivitis, mild–moderate central superficial keratitis (ulcerative), mild anterior uveitis1 | Sparse, mixed bacterial growth dominated by |
| Flunixin (5 days) | |
| 45 | None1 | No bacterial growth | |||
| 160 | No symptoms2 |
Treatment prior to referral and short term medications awaiting culture results not included in the table. 1 Veterinary diagnoses, 2 Owner observation
italic treatment outside clinic, BID treatment twice daily, TID treatment 3 times daily, QID treatment 4 times daily, CF continuous flow via subpalpebral lavage system, underlined: antibiotic treatments
aTypically 3–5 days after sampling
bTopical antibiotics initiated after received culture report